An observational study in Endometrial Cancer, sponsored by Università degli Studi dell'Insubria. Completed. Open to female participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2016-11-15.
Sponsored by Università degli Studi dell'Insubria · Observational
The investigators sought to retrospectively assess whether the use of a intrauterine device to manipulate the uterus does affect the long-term oncologic outcomes of patients operated by laparoscopy for endometrial cancer
The investigators retrospectively collected data regarding patients who received operation by laparoscopy for presumed clinical stage I endometrial cancer. The subjects were then stratified according to the use or not of the uterine manipulator. The investigators also considered the actual type of manipulator used. Then disease-free, disease-specific and overall survival were evaluated, as well as all the possible factors associated with prognosis.
Data were retrieved from specifically designed research quality internal surgical databases, prospectively updated by trained residents on a regular basis, in order to capture all the possible surgical and follow-up data.
1,325 studies on the registry are indexed under Endometrial Neoplasms; 447 are open to participants now.
This study's enrollment of 951 is above the median of 179 across 321 observational studies indexed under Endometrial Neoplasms.
Browse Endometrial Neoplasms studies →Università degli Studi dell'Insubria is the lead sponsor of 67 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women affected by early endometrial cancer
Exclusion Criteria:
Patients who were operated for endometrial cancer by laparoscopy with the use of a uterine manipulator
Device: UTERINE MANIPULATOR
Patients who were operated for endometrial cancer by laparoscopy without the use of a uterine manipulator
Patients were operated laparoscopically with the aid or not of an intrauterine probe to manipulate the uterus
Disease recurrence
Relapse of disease during follow-up
Time frame: 4 years
disease specific survival
Kaplan Meyer curves and Log-rank test to explore disease-specific survival
Time frame: 4 years
overall survival
Kaplan Meyer curves and Log-rank test to explore overall survival
Time frame: 4 years
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Università degli Studi dell'Insubria